Complete Filing Data
Inmune Bio, Inc. reported Stockholders Equity of $23.52 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Inmune Bio, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$45.9M | -$42.1M | -$30.0M | -$27.3M | -$30.3M | -$12.1M | -$7.7M | -$12.4M | -$831.5K |
| General And Administrative Expense | $10.3M | $9.5M | $9.6M | $9.3M | $8.8M | $6.3M | $6.0M | $9.1M | $546.1K |
| Research And Development Expense | $20.7M | $33.2M | $20.3M | $17.1M | $20.5M | $5.9M | $3.3M | $3.4M | $435.4K |
| Operating Income Loss | -$47.4M | -$42.6M | -$29.7M | -$26.0M | -$29.2M | -$12.2M | -$7.8M | -$12.4M | -$981.5K |
| Operating Expenses | $47.4M | $42.6M | $29.9M | $26.3M | $29.3M | $12.2M | $7.8M | $12.4M | $981.5K |
| Comprehensive Income Net Of Tax | -$46.1M | -$41.9M | -$30.1M | -$28.0M | -$30.4M | -$12.1M | -$7.7M | -$12.5M | -$796.6K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$162.0K | $224.0K | -$100.0K | -$700.0K | -$10.0K | $20.0K | -$15.0K | -$25.5K | |
| Revenues | $50.0K | $14.0K | $155.0K | $374.0K | $181.0K | $11.0K | $0.00 | $0.00 | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$700.0K | -$10.0K | $20.0K | -$15.0K | -$25.5K | ||||
| Research And Development Tax Credit Receivable | $8.1M | $4.9M | $1.7M | $568.1K | $592.2K | $106.9K | |||
| Other Nonoperating Income Expense | $553.0K | -$267.0K | -$1.3M | $128.5K | $77.7K | $150.0K | |||
| Nonoperating Income Expense | $1.5M | $553.0K | -$267.0K | -$1.2M | $129.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.5M | -$24.5M | -$9.7M | -$12.1M | -$9.7M | -$11.0M | -$8.6M | -$6.5M | -$6.5M | -$7.7M | -$6.8M | -$6.9M | -$9.5M | -$6.7M | -$4.6M | -$4.7M | -$2.1M | -$2.1M | -$3.1M | -$392.1K | -$1.9M | -$1.5M | -$6.2M | -$2.8M | |
| General And Administrative Expense | $2.5M | $2.3M | $2.3M | $2.2M | $2.8M | $2.3M | $2.6M | $2.3M | $2.3M | $2.4M | $2.2M | $2.3M | $2.5M | $2.1M | $2.1M | $2.5M | $1.2M | $1.3M | $1.9M | $1.3M | $1.3M | $885.2K | $5.9M | $2.7M | |
| Research And Development Expense | $4.9M | $5.8M | $7.6M | $10.1M | $7.1M | $8.7M | $6.0M | $4.1M | $4.1M | $5.2M | $4.2M | $4.3M | $6.5M | $4.5M | $2.5M | $2.4M | $903.0K | $793.0K | $1.2M | $634.7K | $612.7K | $654.7K | $287.3K | $104.0K | |
| Operating Income Loss | -$7.4M | -$24.6M | -$9.9M | -$12.3M | -$9.9M | -$11.0M | -$8.5M | -$6.4M | -$6.4M | -$7.4M | -$6.4M | -$6.5M | -$9.0M | -$6.6M | -$4.5M | -$4.8M | -$2.1M | -$2.1M | -$3.1M | -$428.4K | -$1.9M | -$1.5M | -$6.2M | -$2.8M | |
| Operating Expenses | $7.4M | $24.6M | $10.0M | $12.3M | $9.9M | $11.0M | $8.6M | $6.5M | $6.5M | $7.5M | $6.4M | $6.6M | $9.0M | $6.6M | $4.6M | $4.8M | $2.1M | $2.1M | $3.1M | $428.4K | $1.9M | $1.5M | $6.2M | $2.8M | |
| Comprehensive Income Net Of Tax | -$6.5M | -$24.6M | -$9.8M | -$12.4M | -$9.8M | -$10.9M | -$8.6M | -$6.5M | -$6.5M | -$8.2M | -$7.6M | -$6.8M | -$9.5M | -$6.7M | -$4.6M | -$4.8M | -$2.1M | -$2.1M | -$3.1M | -$417.1K | -$1.9M | -$1.5M | -$6.2M | -$2.8M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.0K | -$153.0K | -$35.0K | -$323.0K | -$44.0K | $130.0K | -$23.0K | -$4.0K | -$9.0K | -$441.0K | -$757.0K | $55.0K | -$68.0K | -$62.0K | $1.0K | -$47.0K | $39.0K | -$21.0K | -$35.5K | -$25.0K | -$722.00 | -$7.6K | |||
| Revenues | $50.0K | $14.0K | $43.0K | $46.0K | $38.0K | $98.0K | $16.0K | $163.0K | $14.0K | $4.0K | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$4.0K | -$9.0K | -$441.0K | -$757.0K | $55.0K | -$68.0K | -$62.0K | $1.0K | -$47.0K | $39.0K | -$21.0K | -$35.5K | -$25.0K | -$722.00 | -$7.6K | -$30.0K | $14.4K | ||||||||
| Research And Development Tax Credit Receivable | $2.1M | $1.9M | $2.1M | $1.9M | $1.8M | $4.4M | $4.9M | $5.1M | $5.0M | $3.1M | $2.2M | $1.5M | $1.0M | $713.1K | $954.0K | $843.7K | $605.7K | ||||||||
| Other Nonoperating Income Expense | $166.0K | -$8.0K | -$8.0K | $102.5K | -$395.00 | $22.0K | $17.2K | $36.3K | $10.0K | ||||||||||||||||
| Nonoperating Income Expense | $961.0K | $113.0K | $193.0K | $119.0K | -$35.0K | -$425.0K | -$437.0K | -$101.0K | -$8.0K | $103.0K | -$1.0K | $22.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $23.5M | $32.1M | $37.3M | $60.1M | $80.2M | $38.8M | $23.6M | $16.5M | $18.1M | -$149.2K |
| Cash And Cash Equivalents At Carrying Value | $24.8M | $20.9M | $35.8M | $52.2M | $74.8M | $22.0M | $7.0M | $186.2K | $1.4M | $141.7K |
| Retained Earnings Accumulated Deficit | -$209.0M | -$163.1M | -$121.0M | -$91.0M | -$63.7M | -$33.4M | -$21.3M | -$13.6M | -$1.2M | |
| Liabilities And Stockholders Equity | $32.4M | $39.6M | $57.0M | $81.8M | $99.9M | $40.7M | $24.5M | $17.4M | $18.4M | |
| Liabilities | $8.8M | $7.5M | $18.9M | $21.7M | $19.7M | $1.9M | $860.5K | $823.8K | $309.7K | |
| Common Stock Value | $27.0K | $22.0K | $18.0K | $18.0K | $18.0K | $13.0K | $10.8K | $8.7K | $8.3K | |
| Assets Current | $29.9M | $22.7M | $39.9M | $64.7M | $82.6M | $24.0M | $7.8M | $849.3K | $1.9M | |
| Assets | $32.4M | $39.6M | $57.0M | $81.8M | $99.9M | $40.7M | $24.5M | $17.4M | $18.4M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$737.0K | -$575.0K | -$799.0K | -$699.0K | $1.0K | $11.0K | -$8.5K | $6.5K | $32.0K | |
| Accounts Payable And Accrued Liabilities Current | $7.8M | $6.5M | $7.9M | $5.2M | $3.7M | $1.5M | $402.0K | $553.2K | $126.3K | |
| Intangible Assets Net Excluding Goodwill | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | ||
| Liabilities Current | $8.4M | $7.2M | $18.5M | $10.9M | $4.4M | $1.8M | $700.4K | $823.8K | ||
| Operating Lease Liability Noncurrent | $411.0K | $244.0K | $397.0K | $526.0K | $126.0K | $160.2K | ||||
| Operating Lease Liability Current | $623.0K | $140.0K | $119.0K | $87.0K | $34.0K | $8.3K | ||||
| Operating Lease Right Of Use Asset | $914.0K | $307.0K | $414.0K | $507.0K | $726.0K | $156.0K | $191.5K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $24.8M | $20.9M | $35.8M | $52.2M | $74.8M | $22.0M | ||||
| Value Added Tax Receivable Current | $591.0K | $113.0K | $77.2K | $37.4K | $111.6K | |||||
| Other Liabilities Current | $517.0K | $489.0K | $616.0K | $474.0K | $190.0K | |||||
| Accounts Payable Related Parties Current | $9.0K | $80.0K | $34.0K | $290.1K | $270.5K | $183.5K | ||||
| Other Assets Noncurrent | $595.0K | $79.0K | $131.0K | $99.0K | $99.0K | |||||
| Cash And Cash Equivalents Period Increase Decrease | $52.8M | $15.0M | $6.8M | -$1.2M | $1.2M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.8M | -$14.9M | -$16.3M | -$22.7M | $52.8M | |||||
| Amortization Of Debt Discount Premium | $79.0K | $224.0K | $239.0K | $126.0K | ||||||
| Prepaid Expense And Other Assets Current | $595.0K | $331.0K | $1.5M | $4.0M | $14.0K | |||||
| Increase Decrease Operating Lease Liability Related Party | $46.0K | $27.0K | -$23.1K | |||||||
| Common Stock Issuable | $50.0K | $4.7M | $50.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $25.4M | $28.9M | $29.7M | $38.7M | $36.3M | $28.2M | $43.9M | $50.7M | $55.3M | $60.1M | $63.7M | $69.9M | $75.6M | $88.3M | $43.2M | $63.6M | $41.2M | $21.7M | $22.4M | $24.7M | $26.8M | $22.9M | $17.5M | $18.0M | $18.6M | |
| Cash And Cash Equivalents At Carrying Value | $27.7M | $33.4M | $19.3M | $33.6M | $31.1M | $26.0M | $41.8M | $47.8M | $51.0M | $57.4M | $61.2M | $66.7M | $84.5M | $39.5M | $45.3M | $24.3M | $4.8M | $5.9M | $7.4M | $9.4M | $6.0M | $650.9K | $1.1M | $2.0M | ||
| Retained Earnings Accumulated Deficit | -$203.8M | -$197.3M | -$172.8M | -$153.9M | -$141.8M | -$132.0M | -$112.6M | -$104.1M | -$97.6M | -$85.2M | -$77.5M | -$70.6M | -$54.0M | -$44.6M | -$37.9M | -$30.2M | -$25.5M | -$23.3M | -$19.0M | -$15.9M | -$15.5M | |||||
| Liabilities And Stockholders Equity | $33.4M | $37.7M | $37.8M | $52.8M | $52.5M | $46.8M | $62.7M | $69.7M | $74.0M | $83.8M | $87.8M | $94.4M | $107.7M | $60.7M | $65.9M | $42.8M | $23.0M | $23.7M | $25.4M | $27.5M | $23.6M | |||||
| Liabilities | $8.0M | $8.8M | $8.1M | $14.1M | $15.4M | $17.8M | $18.0M | $19.1M | $18.7M | $20.1M | $17.9M | $18.7M | $19.4M | $17.5M | $2.3M | $1.6M | $1.4M | $1.3M | $687.0K | $692.7K | $780.9K | |||||
| Common Stock Value | $27.0K | $27.0K | $23.0K | $22.0K | $20.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $15.0K | $15.0K | $13.4K | $10.9K | $10.7K | $10.8K | $10.8K | $9.7K | |||||
| Assets Current | $30.7M | $36.0M | $21.0M | $35.9M | $35.5M | $29.8M | $45.6M | $52.6M | $56.9M | $66.7M | $70.5M | $77.1M | $90.9M | $44.0M | $49.2M | $26.1M | $6.4M | $7.0M | $8.7M | $10.8M | $7.1M | |||||
| Assets | $33.4M | $37.7M | $37.8M | $52.8M | $52.5M | $46.8M | $62.7M | $69.7M | $74.0M | $83.8M | $87.8M | $94.4M | $107.7M | $60.7M | $65.9M | $42.8M | $23.0M | $23.7M | $25.4M | $27.5M | $23.6M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$764.0K | -$763.0K | -$610.0K | -$1.0M | -$713.0K | -$669.0K | -$735.0K | -$712.0K | -$708.0K | -$1.1M | -$701.0K | $56.0K | -$118.0K | -$50.0K | $12.0K | -$37.7K | $10.1K | -$29.3K | -$54.7K | -$19.2K | $5.8K | |||||
| Accounts Payable And Accrued Liabilities Current | $6.9M | $7.7M | $7.2M | $10.6M | $9.3M | $9.3M | $3.7M | $2.4M | $2.1M | $3.5M | $1.7M | $2.6M | $4.2M | $2.4M | $1.6M | $1.2M | $624.9K | $695.7K | $337.2K | $438.2K | $471.6K | |||||
| Intangible Assets Net Excluding Goodwill | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | |||||||
| Liabilities Current | $7.4M | $8.6M | $7.9M | $13.8M | $15.1M | $17.5M | $14.4M | $13.1M | $10.3M | $6.9M | $2.3M | $3.2M | $4.8M | $3.0M | $2.2M | $1.5M | $1.2M | $1.1M | $515.5K | $515.6K | ||||||
| Operating Lease Liability Noncurrent | $623.0K | $231.0K | $201.0K | $284.0K | $322.0K | $360.0K | $430.0K | $463.0K | $498.0K | $607.0K | $645.0K | $684.0K | $284.0K | $95.0K | $106.0K | $116.0K | $136.0K | $145.4K | $154.3K | $171.5K | $177.1K | |||||
| Operating Lease Liability Current | $457.0K | $220.0K | $146.0K | $135.0K | $130.0K | $125.0K | $106.0K | $101.0K | $106.0K | $144.0K | $113.0K | $82.0K | $135.0K | $38.0K | $36.0K | $23.0K | $20.2K | $7.0K | $18.4K | $16.2K | $7.5K | |||||
| Operating Lease Right Of Use Asset | $1.1M | $374.0K | $278.0K | $335.0K | $363.0K | $389.0K | $444.0K | $468.0K | $485.0K | $529.0K | $650.0K | $681.0K | $128.0K | $137.0K | $147.0K | $165.4K | $174.6K | $182.7K | $199.2K | $209.2K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $27.7M | $33.4M | $19.3M | $33.6M | $31.1M | $26.0M | $41.8M | $47.8M | $51.0M | $57.4M | $61.2M | $66.7M | ||||||||||||||
| Value Added Tax Receivable Current | $176.0K | $112.0K | $396.0K | $362.0K | $114.0K | $134.0K | $499.0K | $188.0K | $51.0K | $154.0K | $143.7K | $155.0K | $71.2K | $105.8K | $104.7K | $165.6K | ||||||||||
| Other Liabilities Current | $511.0K | $480.0K | $549.0K | $521.0K | $520.0K | $496.0K | $560.0K | $591.0K | $778.0K | $476.0K | $584.0K | $541.0K | $583.0K | $591.0K | $253.7K | $361.8K | $300.0K | |||||||||
| Accounts Payable Related Parties Current | $8.0K | $9.0K | $9.0K | $10.0K | $9.0K | $10.0K | $9.1K | $223.6K | $102.9K | $162.1K | $69.9K | $9.2K | ||||||||||||||
| Other Assets Noncurrent | $746.0K | $570.0K | $49.0K | $82.0K | $81.0K | $106.0K | $129.0K | $130.0K | $99.0K | $99.0K | $99.0K | $99.0K | $99.0K | |||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $23.4M | -$1.1M | $5.9M | $585.6K | ||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.6M | -$9.8M | -$1.2M | -$8.1M | $23.4M | |||||||||||||||||||||
| Amortization Of Debt Discount Premium | $34.0K | $67.0K | $56.0K | |||||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $472.0K | $505.0K | $207.0K | $864.0K | $1.0M | $1.1M | $1.5M | $2.7M | $35.0K | |||||||||||||||||
| Increase Decrease Operating Lease Liability Related Party | $35.0K | -$12.0K | $13.0K | |||||||||||||||||||||||
| Common Stock Issuable | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $4.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $9.9M | $7.6M | $7.4M | $7.1M | $4.8M | $3.1M | $4.1M | $10.0M | $199.6K |
| Net Cash Provided By Used In Operating Activities | -$22.6M | -$33.4M | -$12.0M | -$22.7M | -$28.5M | -$8.9M | -$5.4M | -$2.1M | -$761.8K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.9M | -$1.4M | $2.7M | $1.5M | $2.2M | $1.1M | -$151.2K | $427.0K | $68.5K |
| Net Cash Provided By Used In Financing Activities | $27.6M | $18.2M | -$4.2M | $729.0K | $96.4M | $23.9M | $12.2M | $900.0K | $2.1M |
| Increase Decrease In Prepaid Expense | $264.0K | -$1.2M | $1.7M | $2.1M | $122.0K | $82.1K | -$27.1K | $39.6K | |
| Increase Decrease In Accounts Payable Related Parties | -$10.0K | $26.0K | -$71.0K | $46.0K | -$40.0K | $19.6K | $87.1K | $170.4K | |
| Proceeds From Issuance Of Common Stock | $27.5M | $27.8M | $775.0K | $699.0K | $80.3M | $24.9M | $12.2M | $900.0K | $2.1M |
| Increase Decrease In Prepaid Expense Related Party | $20.0K | $14.0K | -$26.0K | $26.3K | -$158.5K | $112.0K | |||
| Increase Decrease In Income Taxes Receivable | $175.0K | -$229.0K | $3.2M | $1.1M | -$24.1K | $485.3K | $38.0K | ||
| Increase Decrease In Other Tax Receivable | $478.0K | $36.0K | $39.8K | -$74.2K | $76.4K | ||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | -$10.0K | $19.0K | -$15.0K | -$25.5K | $34.9K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$159.0K | $224.0K | -$100.0K | -$700.0K | -$10.0K | ||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $9.9M | $7.6M | $7.4M | $7.1M | |||||
| Increase Decrease In Operating Lease Liability | $43.0K | -$25.0K | -$4.0K | -$33.0K | $46.0K | ||||
| Increase Decrease In Other Receivables | $29.0K | -$309.0K | $175.0K | -$229.0K | $478.0K | ||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$550.0K | $351.0K | $199.0K | ||||||
| Increase Decrease In Joint Development Cost Receivable | $18.0K | $91.1K | $47.3K | ||||||
| Increase Decrease In Deferred Liabilities | -$517.0K | $28.0K | -$127.0K | $142.0K | |||||
| Proceeds From Warrant Exercises | $1.0K | $30.0K | $18.0K | ||||||
| Increase Decrease In Other Operating Assets | $516.0K | -$52.0K | $32.0K | $99.0K | |||||
| Net Cash Provided By Used In Investing Activities | -$1.0M | -$15.0M | -$100.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $2.1M | $1.8M | $1.7M | $1.9M | $1.9M | $1.5M | $1.6M | $769.0K | $899.0K | $1.0M | $681.7K | $682.0K | $974.7K | $974.7K | $974.7K | $979.6K | $2.5M | ||||||
| Net Cash Provided By Used In Operating Activities | -$6.8M | -$7.5M | -$1.1M | -$8.9M | -$5.1M | -$1.0M | -$1.4M | -$328.8K | |||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $659.0K | $1.4M | -$3.1M | -$1.2M | $54.0K | $294.0K | -$174.0K | $60.2K | |||||||||||||||
| Net Cash Provided By Used In Financing Activities | $5.3M | -$2.5M | $729.0K | $28.5M | -$9.0K | $7.3M | $900.0K | ||||||||||||||||
| Increase Decrease In Prepaid Expense | -$401.0K | -$394.0K | $2.4M | $1.3M | $170.0K | $179.2K | -$18.7K | ||||||||||||||||
| Increase Decrease In Accounts Payable Related Parties | $78.0K | $21.0K | -$71.0K | -$24.0K | $29.0K | -$168.9K | -$173.6K | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | $5.3M | $28.4M | $1.0M | $7.3M | $900.0K | ||||||||||||||||||
| Increase Decrease In Prepaid Expense Related Party | $1.0K | $15.0K | -$26.0K | $81.0K | -$51.4K | ||||||||||||||||||
| Increase Decrease In Income Taxes Receivable | $20.0K | $34.0K | $504.0K | $145.0K | $13.5K | $54.8K | |||||||||||||||||
| Increase Decrease In Other Tax Receivable | $41.0K | -$6.0K | $128.2K | -$55.9K | |||||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $1.0K | -$21.0K | -$722.00 | $14.4K | |||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$35.0K | $130.0K | -$9.0K | $55.0K | $1.0K | ||||||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $3.0M | $1.5M | $2.1M | $1.7M | $2.4M | $1.8M | $1.9M | $1.9M | $1.7M | ||||||||||||||
| Increase Decrease In Operating Lease Liability | -$8.0K | -$6.0K | $13.0K | $35.0K | |||||||||||||||||||
| Increase Decrease In Other Receivables | -$95.0K | $20.0K | $34.0K | -$92.0K | |||||||||||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $88.0K | $88.0K | |||||||||||||||||||||
| Increase Decrease In Joint Development Cost Receivable | -$16.5K | $98.2K | |||||||||||||||||||||
| Increase Decrease In Deferred Liabilities | -$37.0K | $31.0K | -$25.0K | ||||||||||||||||||||
| Proceeds From Warrant Exercises | $1.0K | $30.0K | $18.0K | ||||||||||||||||||||
| Increase Decrease In Other Operating Assets | -$30.0K | -$25.0K | |||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.86 | -$2.11 | -$1.67 | -$1.52 | -$1.88 | -$1.01 | -$0.75 | -$1.43 | -$0.13 |
| Common Stock Shares Issued | 26.6M | 22.3M | 18.0M | 17.9M | 17.8M | 13.5M | 10.8M | 8.7M | 8.3M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Common Stock Shares Outstanding | 26.6M | 22.3M | 18.0M | 17.9M | 17.8M | 13.5M | 10.8M | 8.7M | 8.3M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 24.8M | 19.9M | 18.0M | 17.9M | 16.1M | ||||
| Earnings Per Share Basic | $-1.86 | $-2.11 | $-1.67 | $-1.52 | $-1.88 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 16.1M | 12.0M | 10.3M | 8.7M | 6.6M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 24.8M | 19.9M | 18.0M | 17.9M | 16.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.24 | -$1.05 | -$0.43 | -$0.60 | -$0.50 | -$0.61 | -$0.48 | -$0.36 | -$0.36 | -$0.43 | -$0.38 | -$0.39 | -$0.55 | -$0.44 | -$0.32 | -$0.36 | -$0.20 | -$0.19 | -$0.28 | -$0.04 | -$0.20 | -$0.18 | -$0.71 | -$0.33 |
| Common Stock Shares Issued | 26.6M | 26.6M | 22.9M | 22.2M | 19.7M | 18.0M | 17.9M | 17.9M | 17.9M | 17.9M | 17.9M | 17.9M | 17.8M | 15.1M | 14.9M | 13.4M | 10.9M | 10.7M | 10.8M | 10.8M | 9.7M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Common Stock Shares Outstanding | 26.6M | 26.6M | 22.9M | 22.2M | 19.7M | 18.0M | 17.9M | 17.9M | 17.9M | 17.9M | 17.9M | 17.9M | 17.8M | 15.1M | 14.9M | 13.4M | 10.9M | 10.7M | 10.8M | 10.8M | 9.7M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 26.6M | 23.3M | 22.5M | 20.2M | 19.3M | 18.0M | 18.0M | 17.9M | 17.9M | 17.9M | 17.9M | 17.9M | 17.3M | 15.0M | 14.3M | |||||||||
| Earnings Per Share Basic | $-0.24 | $-1.05 | $-0.43 | $-0.60 | $-0.50 | $-0.61 | $-0.48 | $-0.36 | $-0.36 | $-0.43 | $-0.38 | $-0.39 | $-0.55 | $-0.44 | $-0.32 | |||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 17.3M | 15.0M | 14.3M | 12.9M | 10.8M | 10.7M | 10.8M | 10.2M | 9.4M | 8.7M | 8.7M | 8.5M | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 26.6M | 23.3M | 22.5M | 20.2M | 19.3M | 18.0M | 18.0M | 17.9M | 17.9M | 17.9M | 17.9M | 17.9M | 17.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $233.3M | $195.8M | $159.1M | $151.8M | $143.9M | $72.1M | $44.8M | $25.4M | $19.2M |
| Stock Issued During Period Value New Issues | $27.5M | $2.4M | $775.0K | $699.0K | $24.9M | $900.0K | $2.1M | ||
| Prepaid Expense Current | $2.3M | $220.0K | $97.6K | $15.6K | $42.6K | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.1M | $4.1M | $5.4M | $199.6K | |||||
| Interest Paid Net | $1.7M | $1.8M | $1.4M | $559.0K | $0.00 | $0.00 | |||
| Prepaid Expenses Related Party | $26.3K | $158.5K | |||||||
| Other Expenses | $1.3M | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $229.9M | $226.9M | $203.1M | $193.6M | $178.8M | $160.9M | $157.3M | $155.4M | $153.5M | $150.0M | $148.1M | $146.2M | $142.4M | $87.9M | $101.5M | $71.4M | $47.1M | $45.7M | $43.7M | $42.7M | $33.7M | |||||
| Stock Issued During Period Value New Issues | $22.3M | $5.3M | $2.0M | $775.0K | $699.0K | $51.8M | $28.4M | $23.2M | $664.0K | $1.0M | $5.0M | $900.0K | ||||||||||||||
| Prepaid Expense Current | $30.0K | $3.6M | $34.0K | $4.6M | $4.2M | $4.7M | $1.3M | $1.4M | $1.5M | $216.9K | $342.5K | $266.4K | $122.0K | $200.0K | $275.8K | |||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $769.0K | $899.0K | $1.0M | $681.0K | $682.0K | $974.7K | $974.7K | $974.7K | $979.6K | $979.6K | $2.5M | |||||||||||||||
| Interest Paid Net | $302.0K | $450.0K | $291.0K | $0.00 | $0.00 | |||||||||||||||||||||
| Prepaid Expenses Related Party | $123.0K | $51.0K | $14.0K | $14.0K | $14.0K | $15.0K | $15.0K | $118.6K | $244.9K | |||||||||||||||||
| Other Expenses | $35.0K | $90.0K | $113.0K | $282.0K | $450.0K | $425.0K | $437.0K | $101.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.